PALISADE BIO, INC. (PALI) Free cash flow 2016–2024
PALISADE BIO, INC. (PALI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.2MFY2024 · since FY2016: -$15.7M → -$12.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$12.2M | -9.5% |
| FY2023 | -$11.1M | +16.7% |
| FY2022 | -$13.4M | +9.5% |
| FY2021 | -$14.8M | -209.4% |
| FY2020 | -$4.8M | — |
| FY2018 | -$7.7M | +42.7% |
| FY2017 | -$13.4M | +14.6% |
| FY2016 | -$15.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice